Multifaceted Intervention to Restore Resilience and Overcome Risk
Key facts
- Who runs it
- Icahn School of Medicine at Mount Sinai
- Where
- Houston, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 136 people, planned
- Started
- 12 Sept 2025
- Expected to end
- 31 Aug 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- webSTAIR
- ExpoTx
- PsychoEd
- Record updated
- 21 September 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Able to consent as determined by UBACC, are English-speaking FVets who are 18+ years old
- Screen positive for exposure to IPV and/or MST using the VA Intimate Partner Violence Assistance Program (VA IPVAP) and MST Screening Protocol,
- Have a history of at least one BI assessed using the BISQ+IPV,
- Sub-threshold PTSD (operationalized as a total score of >33 on the PTSD Checklist Diagnostic and Statistical Manual of Mental Disorders-5 (PCL-5),
- Report deficits in Emotion Regulation (operationalized as a score of 0.5 SD above published means on the DERS)
Who cannot take part
- Those determined to have problematic substance use (score > 27 on the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) will be referred to substance use dependence programs for concurrent treatment. The PI and Co-Is will collaborate with the substance use dependence program to determine continued participation
- FVets at high risk for suicide (respond yes to items 3, 4, 5, or 8 on the Columbia Suicide Severity Rating Scale [C-SSRS]), will be initially excluded until a secondary risk and safety assessment is completed by one of the Texas licensed study psychologists, who will use the VA Comprehensive Suicide Risk Evaluation (CSRE) to determine planning and intentions. Veterans who endorse chronic thoughts of death found among those with PTSD and depression, but who have no suicidal behaviors with intent to act, based on secondary risk assessment, will be included in the study
- Observable active psychosis (e.g., auditory hallucinations, grandiose delusions),
Where in United States
- Baylor College of MedicineHouston, United StatesContact: Kameron Simmons, M.S.Taking people
About the trial
What the trial wants to find out
The MIRROR study will compare the effectiveness of two interventions in improving emotion regulation and reducing PTSD symptoms in female Veterans with military sexual trauma (MST) and/or intimate partner violence (IPV) and co-occurring brain injury.
The 2 groups in the trial
- webSTAIR+ExpoTxTreatment being tested
Web-based technology "webSTAIR" (Web-Based Skills Training in Affective Regulation and Interpersonal Relationships Program) will be used to guide Female Veterans (FVets) through each of the 10 webSTAIR skill modules for 5-weeks followed by 5 weeks of standard, patient-centered, exposure therapy (ExpoTx) delivered by a therapist.
Treatment: webSTAIR and ExpoTx
- PsychoEd+ExpoTxExisting treatment, for comparison
5 online sessions of psycho-education followed by 5 online sessions of exposure therapy
Treatment: ExpoTx and PsychoEd
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 21 September 2026